Tag Archives: Bayer

Clinical Trials: How to get things right?

The issue of Clinical Trials in India has once again come to the fore with the government’s efforts to woo the mighty pharma industry. The Drug Controller General of India, Mr G N Singh, has been quoted as saying that India will soon roll out a new policy to facilitate clinical trials. It is hence important to understand what are we talking about and why we need to get it right.

Posted in EDITOR'S CHOICE, OPINIONS, The Antagoniser | Tagged , , , , , , , , | Leave a comment

India’s free health camps threatening patients’ wellbeing

London: The sprouting “free health check-up camps” in India are just a tactic of pharmaceutical companies to push their products and are in violation of the Medical Council of India (MCI) guidelines, says a special investigative report in the British Medical Journal.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , , , , , , | 1 Comment

FDA approves Adempas to treat pulmonary hypertension

Washington: The US Food and Drug Administration has approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , | Leave a comment

iPhone device detects heart rhythm problem that can cause stroke

Sydney: A special iPhone case and app can be used to quickly and cheaply detect heart rhythm problems and prevent strokes, according to University of Sydney research.

Posted in Medical Technology, NEWS | Tagged , , , , , , , , , , , , , | Leave a comment

Public not to be hit if Natco Pharma licence cancelled: Bayer

Chennai: The cancellation of a compulsory licence to Hyderabad-based Natco Pharma Ltd to make and sell the generic equivalent of cancer drug Nexavar will not impact public interest as there is another company selling it at a lower price, the Bayer Corporation said here on Monday.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , | Leave a comment

US pushing India to hike cancer drug price

Washington: Even as President Barack Obama is plugging his signature law to lower health care costs at home, his administration is pressurising India and other countries to impose higher prices even for lifesaver cancer drugs.

Posted in NEWS | Tagged , , , , , , , | Leave a comment

Abbott, AstraZeneca, Bayer, Eli Lilly, GSK, Merck, Sanofi join hands for new TB drug

New Delhi: Pharmaceutical companies and research institutions in association with the Bill and Melinda Gates Foundation have stepped up efforts to aid research on a new drug for tuberculosis (TB), a disease that annually kills about three lakh people in India.

Posted in NEWS | Tagged , , , , , , , , , , , , , , | Leave a comment

Doctors acting as a rubber stamp for drug companies?

New Delhi: A report by the parliamentary standing committee for health and family welfare, which looked at the functioning of the Central Drugs Standard Control Organization (CDSCO), reveals that some drug companies have been writing scientific recommendations of their own products and submitting them to the Drug Controller General of India (DCGI) after getting them endorsed by top doctors for a quicker marketing approval.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

Natco allowed to sell generic version of Bayer’s cancer drug Nexavar in India

Mumbai: The Controller General of Patents, Designs and Trade Marks has allowed Hyderabad-based Natco Pharma to manufacture and market the generic version of a patented cancer drug, Nexavar, in India for Rs 8,880 per month, just 3 per cent of the price charged by Germany’s Bayer AG. In return, Natco will have to pay Bayer royalty pegged at six per cent of the net sales, every quarter.

Posted in NEWS | Tagged , , , , , , , , , , | Leave a comment